After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
RMD belongs to the Healthcare sector of the NYSE while operating in the Medical Instruments & Supplies industry. The current market capitalization of Resmed Inc is $34.32B. A total of 1.04 million shares were traded on the day, compared to an average of 887.86K shares.
In the most recent transaction, Sandercock Brett sold 1,000 shares of RMD for 234.04 per share on Jan 08 ’25. After the transaction, the Chief Financial Officer now owns 92,864 company shares. In a previous transaction on Jan 08 ’25, Sandercock Brett bought 1,000 shares at 234.04 per share.
Among the insiders who sold shares, FARRELL PETER C disposed of 2,000 shares on Jan 02 ’25 at a per-share price of $230.99. This resulted in the Director holding 79,218 shares of RMD after the transaction. In another insider transaction, Rider Michael J sold 75 shares at $230.99 per share on Jan 02 ’25. Company shares held by the Global General Counsel now total 9,038.
Dividend
Paying dividends generates immediate cash flow for investors and indicates a positive outlook for the company. Resmed Inc pays an annual dividend of $2.02, resulting in a dividend yield of 0.86%, and it has a price to earnings (P/E) ratio of 31.00. RMD’s most recent ex-dividend date was 0.8% when it declared a $0.53 quarterly dividend that was paid in cash on 11/7/2024. Previously, the company paid the dividend on 8/15/2024 with an ex-dividend date of 0.9%. The RMD stock dividend was $0.53 per share in cash.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, RMD has a high of $260.49 and a low of $168.29.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. RMD’s latest balance sheet shows that the firm has $273.71M in Cash & Short Term Investments as of fiscal 2022. There were $917.55M in debt and $689.30M in liabilities at the time. Its Book Value Per Share was $35.39, while its Total Shareholder’s Equity was $3.36B.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RMD is Buy with a score of 3.67.
